Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients

doi:10.3748/wjg.v23.i28.5196

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8564)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

567

WORD

297

HTML

4173

Figures (1-2)

281

Tables (1-3)

184

Sum=5502

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1093

Download

1969

Sum=3062

Jul 28, 2017 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jul 28, 2017; 23(28): 5196-5205
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5196

Table 3 Interaction analysis of metformin and relevant factors on colorectal cancer-specific mortality

	HR	95%CI	P value
Metformin-Sex	0.369	0.155-0.881	0.025
Metformin-BMI	1.000	0.974-1.026	0.972
Metformin-Site	0.941	0.441-2.006	0.875
Metformin-HbA1c	0.999	0.926-1.078	0.979

BMI: Body mass index.

Citation: Park JW, Lee JH, Park YH, Park SJ, Cheon JH, Kim WH, Kim TI. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients. World J Gastroenterol 2017; 23(28): 5196-5205
URL: https://www.wjgnet.com/1007-9327/full/v23/i28/5196.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i28.5196